| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9170486 | Journal of Cardiac Failure | 2005 | 5 Pages |
Abstract
Before routine use of NT-proBNP in NSTACS, the extra cost of adding this new marker to the current routine markers and its impact on selection of treatment should be considered.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Tomas MD, PhD, Stefan MD, PhD, Bertil MD, PhD, Mats MD, PhD, Per MD, PhD, Lars MD, PhD,